Tag Archives: checkpoint inhibitors

November, 2018

April, 2018

June, 2017

November, 2016

  • 11 November

    Bristol-Myers and Johns Hopkins Collaborate on Immuno-Oncology Research

    NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) announced today that the company has entered into a five-year research collaboration with the Johns Hopkins University. The collaboration is designed to identify mechanisms of response and resistance in patients whose cancer is being treated with checkpoint inhibitor-based immunotherapies, including Opdivo (nivolumab) monotherapy, or …

August, 2016

January, 2016

  • 27 January

    Cost and Value

    Where does the true value of cancer treatment lie? Oncology experts grapple with this important question, with one of the more recent people to chime in being Robert C. Young, M.D., of RCY Medicine in Philadelphia, in an essay in a recent issue of the New England Journal of Medicine. Dr. …